Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: study protocol for a randomized phase Ib/IIa trial

BACKGROUND: The gut microbiome plays an important role in immune modulation. Specifically, presence or absence of certain gut bacterial taxa has been associated with better antitumor immune responses. Furthermore, in trials using fecal microbiota transplantation (FMT) to treat melanoma patients unre...

Descripción completa

Detalles Bibliográficos
Autores principales: Borgers, J. S. W., Burgers, F. H., Terveer, E. M., van Leerdam, M. E., Korse, C. M., Kessels, R., Flohil, C. C., Blank, C. U., Schumacher, T. N., van Dijk, M., Henderickx, J. G. E., Keller, J. J., Verspaget, H. W., Kuijper, E. J., Haanen, J. B. A. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801532/
https://www.ncbi.nlm.nih.gov/pubmed/36585700
http://dx.doi.org/10.1186/s12885-022-10457-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801532/
https://www.ncbi.nlm.nih.gov/pubmed/36585700
http://dx.doi.org/10.1186/s12885-022-10457-y

Ejemplares similares